Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 08-2021 | 06-2021 | 05-2021 | 03-2021 | 02-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,629 | N/A | 10,052 | N/A | 10,706 |
| Marketable Securities | 3,436 | N/A | N/A | N/A | 512 |
| Other current assets | 0 | 0 | 73 | 0 | 0 |
| TOTAL | $10,317 | $N/A | $10,300 | $N/A | $11,405 |
| Non-Current Assets | |||||
| Intangibles | 2,039 | 0 | 2,039 | 0 | 2,039 |
| Other Non-Current Assets | 279 | 0 | 0 | 0 | 0 |
| TOTAL | $2,318 | $N/A | $2,040 | $N/A | $2,040 |
| Total Assets | $12,635 | $N/A | $12,340 | $N/A | $13,445 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 498 | 0 | 424 | 0 | 589 |
| TOTAL | $526 | $N/A | $424 | $N/A | $589 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 67 | 0 | 0 | 0 | 0 |
| TOTAL | $67 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $593 | $N/A | $424 | $N/A | $589 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | 91 | N/A | 86 |
| Common Shares | 25 | N/A | 23 | N/A | 22 |
| Retained earnings | -16,903 | N/A | -15,016 | N/A | -12,766 |
| Other shareholders' equity | 18 | 0 | 49 | 0 | 48 |
| TOTAL | $12,042 | $N/A | $11,916 | $N/A | $12,856 |
| Total Liabilities And Equity | $12,635 | $0 | $12,340 | $0 | $13,445 |